This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
momentum-investor: Archive
What Makes Valmont Industries (VMI) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Valmont Industries (VMI) have what it takes to be a top stock pick for momentum investors? Let's find out.
VMINegative Net Change
momentum-investor momentum-stocks price-change volume
Are You Looking for a Top Momentum Pick? Why Heartland Express (HTLD) is a Great Choice
by Zacks Equity Research
Does Heartland Express (HTLD) have what it takes to be a top stock pick for momentum investors? Let's find out.
HTLDPositive Net Change
momentum-investor momentum-stocks price-change volume
Analog Devices (ADI) Is Up 4.23% in One Week: What You Should Know
by Zacks Equity Research
Does Analog Devices (ADI) have what it takes to be a top stock pick for momentum investors? Let's find out.
ADINegative Net Change
momentum-investor momentum-stocks price-change volume
What Makes Vishay Intertechnology (VSH) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Vishay Intertechnology (VSH) have what it takes to be a top stock pick for momentum investors? Let's find out.
VSHPositive Net Change
momentum-investor momentum-stocks price-change volume
Carpenter Technology (CRS) Is Up 8.03% in One Week: What You Should Know
by Zacks Equity Research
Does Carpenter Technology (CRS) have what it takes to be a top stock pick for momentum investors? Let's find out.
CRSPositive Net Change
momentum-investor momentum-stocks price-change volume
Stoke Therapeutics (STOK) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
Stoke Therapeutics (STOK) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
STOKPositive Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Here's Why Sagimet Biosciences Inc. (SGMT) Could be Great Choice for a Bottom Fisher
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Sagimet Biosciences Inc. (SGMT), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
SGMTPositive Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Bears are Losing Control Over Omeros (OMER), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Omeros (OMER) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
OMERPositive Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Omnicell (OMCL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Omnicell (OMCL), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
OMCLPositive Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
IN8bio (INAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for IN8bio (INAB), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
INABNo Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement